An indirect comparison found 1.46 points more weight loss than 25 mg Rybelsus at 52 weeks. GlobalData's analyst says head-to-head trials are still needed.
Recap by typeshit. Full story at Medical Dialogues.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
Two new plans keep one price at every dose, with no membership fee. Prescriptions come from five named 503A pharmacies, and the cheaper plan skips California.
The 80-week Lancet trial of 1,152 adults saw 47% on the 12 mg dose lose at least 20% of their weight, with more nausea and diarrhea than placebo.
Loading…